Switch to
More onapp

How to use scorecard? Learn more

Lincoln Pharmaceuticals Ltd

LINCOLN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,425 cr, stock is ranked 1,183
High RiskStock is 3.88x as volatile as Nifty
687.7523.80 (-3.34%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,425 cr, stock is ranked 1,183
High RiskStock is 3.88x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
16.33
PB RatioPB Ratio
2.84
Dividend YieldDiv. Yield
0.21%
Sector PESector PE
52.46
Sector PBSector PB
6.01
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Financial TrendFinancial statements 

2020202120222023397.53429.85482.12532.7851.4262.2569.3672.89
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.13%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Spurt in Volume 
Announced OnJan 11, 2024

Significant increase in volume has been observed in Lincoln Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Lincoln Pharmaceuticals Limited has submitted their response. | Download

Significant increase in volume has been observed in Lincoln Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Lincoln Pharmaceuticals Limited has submitted their response. | Download

Spurt in Volume 
Announced OnJan 11, 2024
Significant increase in volume has been observed in Lincoln Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Significant increase in volume has been observed in Lincoln Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Cash Dividend 
Ex. DateSep 15, 2023

Final • Div/Share: ₹ 1.5

See all events